Aug 1- Botox maker Allergan Inc on Friday accused rival Valeant Pharmaceuticals International and billionaire investor William Ackman of violating securities laws by using insider information as they prepared a takeover bid for the drug company.» Read More
One share, one vote? Not exactly: the fate of millions of shares and the rights of shareholders may be up for grabs, as the U.S. House Financial Services Committee is considering a bill that would give investors final say over CEO compensation. Two experts debated the wisdom of such a bill, on "Morning Call."
Influential proxy advisory firm Institutional Shareholder Services said on Tuesday it recommends that Caremark Rx shareholders support a takeover proposal from drugstore chain CVS, reversing its previous stance.
In a sign that the New York Times may be trying to appease investors who have criticized it, the newspaper publisher invited Morgan Stanley money manager Hassan Elmasry and another large shareholder, T. Rowe Price Group, to make presentations to its board of directors late last month, The Wall Street Journal reported.
Should companies stop issuing quarterly earnings guidance? That was a major topic of discussion on today's "Morning Call." Dean , executive director of the Business Roundtable Institute for Corporate Ethics, says yes because focusing on quarterly earnings per share guidance often forces companies to concentrate on the here-and-now while under-investing in the future.
We've mentioned today's report on global warming in an earlier post--so let's get right to one of the major questions: is corporate America taking global warming as a serious issue or not? Some are it seems as reported earlier this month when 10 companies and their CEOs joined activist groups in calling for caps on carbon emissions.
From energy to gold, airlines to the Internet, specialists and analysts offer predictions for the new year, as our "7 For '07" special coverage continues. And don't miss our 2007 Money Manager Survey.